Imipenem for Treatment of Tuberculosis in Mice and Humans

Por Chambers, Henry F., Turner, Joan, Schecter, Gisela F., Kawamura, Masae, Hopewell, Philip C.
Publicado em 2005

Clinical Impact on Tuberculosis Treatment Outcomes of Discordance Between Molecular and Growth-Based Assays for Rifampin Resistance, California 2003–2013

Por Shah, Neha S., Grace Lin, SY, Barry, Pennan M., Cheng, Yi-Ning, Schecter, Gisela, Desmond, Ed
Publicado no Open Forum Infect Dis (2016)

Intestinal Parasites in Southeast Asian Refugees

Por Borchardt, Kenneth A., Ortega, Helen, Mahood, Joseph D., Newman, Jeffrey, DeLay, Paul R., Doss, John, Hipkins, Karen, Schecter, Gisela, Gelber, Robert H.
Publicado em 1981

Rapid Drug Susceptibility Testing with a Molecular Beacon Assay Is Associated with Earlier Diagnosis and Treatment of Multidrug-Resistant Tuberculosis in California

Por Banerjee, Ritu, Allen, Jennifer, Lin, S.-Y. Grace, Westenhouse, Janice, Desmond, Ed, Schecter, Gisela F., Scott, Cheryl, Raftery, Ann, Mase, Sundari, Watt, James P., Flood, Jennifer
Publicado em 2010

Rifabutin and Rifampin Resistance Levels and Associated rpoB Mutations in Clinical Isolates of Mycobacterium tuberculosis Complex

Por Berrada, Zenda L., Lin, Shou-Yean Grace, Rodwell, Timothy C., Nguyen, Duylinh, Schecter, Gisela F., Pham, Lucy, Janda, J. Michael, Elmaraachli, Wael, Catanzaro, Antonino, Desmond, Ed
Publicado no Diagn Microbiol Infect Dis (2016)